Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jill E. Elwing, Hadi Atassi, Benjamin D. Rogers & Gregory S. Sayuk. (2022) Emerging therapies in the management of Irritable Bowel Syndrome (IBS). Expert Opinion on Emerging Drugs 27:1, pages 55-73.
Read now
Read now
Jennifer Jones, Anthony Lembo, Joel Heidelbaugh, Louis Kuritzky & Brian Lacy. (2021) Management of irritable bowel syndrome with diarrhea: focus on eluxadoline. Current Medical Research and Opinion 37:4, pages 567-578.
Read now
Read now
Rebecca Liu & Kyle Staller. (2020) Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives. Drug Design, Development and Therapy 14, pages 1391-1400.
Read now
Read now
Brian E Lacy. (2016) Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. International Journal of General Medicine 9, pages 7-17.
Read now
Read now
Judy Nee, Mohammed Zakari & Anthony J Lembo. (2015) Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 16:18, pages 2781-2792.
Read now
Read now
Sylvie Bradesi, Kirsten Tillisch & Emeran Mayer. (2006) Emerging drugs for irritable bowel syndrome. Expert Opinion on Emerging Drugs 11:2, pages 293-313.
Read now
Read now
Ashkan Farhadi, Keith Bruninga, Jeremy Fields & Ali Keshavarzian. (2001) Irritable bowel syndrome: an update on therapeutic modalities. Expert Opinion on Investigational Drugs 10:7, pages 1211-1222.
Read now
Read now
Articles from other publishers (92)
Ankita Wal, Pranay Wal, Neha Verma, Awani Kumar Rai & Piyush Vatsha. (2023) Mechanism, Pathophysiology and Herbal Management-A Review on
Irritable Bowel Syndrome. The Natural Products Journal 13:3.
Crossref
Crossref
Daniel Pohl, Stephan Vavricka, Mark Fox, Ahmed Madisch, Diana Studerus, Paul Wiesel, Henriette Heinrich, Ioannis Linas, Alain Schoepfer, Alexandra Schwizer & Stephan Wildi. (2023) Häufige Magen-Darm-Beschwerden: Management der funktionellen Dyspepsie und des Reizdarm-Syndroms in der Praxis. Praxis 112:5-6, pages 304-316.
Crossref
Crossref
Uday C. Ghoshal, Sanjeev Sachdeva, Nitesh Pratap, Arun Karyampudi, Uzma Mustafa, Philip Abraham, Chetan B. Bhatt, Karmabir Chakravartty, Sujit Chaudhuri, Omesh Goyal, Govind K. Makharia, Manas Kumar Panigrahi, Prasanta Kumar Parida, Sudhanshu Patwari, Rajesh Sainani, Shine Sadasivan, M. Srinivas, Rajesh Upadhyay & Jayanthi Venkataraman. (2023) Indian consensus statements on irritable bowel syndrome in adults: A guideline by the Indian Neurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology. Indian Journal of Gastroenterology 42:2, pages 249-273.
Crossref
Crossref
Anthony Lembo, Shahnaz Sultan, Lin Chang, Joel J. Heidelbaugh, Walter Smalley & G. Nicholas Verne. (2022) AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea. Gastroenterology 163:1, pages 137-151.
Crossref
Crossref
Edoardo Savarino, Fabiana Zingone, Brigida Barberio, Giovanni Marasco, Filiz Akyuz, Hale Akpinar, Oana Barboi, Giorgia Bodini, Serhat Bor, Giuseppe Chiarioni, Gheorghe Cristian, Maura Corsetti, Antonio Di Sabatino, Anca Mirela Dimitriu, Vasile Drug, Dan L. Dumitrascu, Alexander C. Ford, Goran Hauser, Radislav Nakov, Nisha Patel, Daniel Pohl, Cătălin Sfarti, Jordi Serra, Magnus Simrén, Alina Suciu, Jan Tack, Murat Toruner, Julian Walters, Cesare Cremon & Giovanni Barbara. (2022) Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility. United European Gastroenterology Journal 10:6, pages 556-584.
Crossref
Crossref
S Kindt, H Louis, H De Schepper, J Arts, P Caenepeel, D De Looze, A Gerkens, T Holvoet, P Latour, T Mahler, F Mokaddem, S Nullens, H Piessevaux, P Poortmans, G Rasschaert, M Surmont, H Vafa, K Van Malderen, T Vanuytsel, F Wuestenberghs & J Tack. (2022) Belgian consensus on irritable bowel syndrome. Acta Gastro Enterologica Belgica 85:2, pages 360-382.
Crossref
Crossref
Eric D. Shah, Jessica K. Salwen-Deremer, Peter R. Gibson, Jane G. Muir, Shanti Eswaran & William D. Chey. (2022) Comparing Costs and Outcomes of Treatments for Irritable Bowel Syndrome With Diarrhea: Cost-Benefit Analysis. Clinical Gastroenterology and Hepatology 20:1, pages 136-144.e31.
Crossref
Crossref
Judy Nee & Anthony Lembo. (2021) Review Article: Current and future treatment approaches for IBS with diarrhoea (IBS‐D) and IBS mixed pattern (IBS‐M). Alimentary Pharmacology & Therapeutics 54:S1.
Crossref
Crossref
Duc Trong Quach, Khoa Tien Vu & Khien Van Vu. (2021) Prevalence, clinical characteristics, and management of irritable bowel syndrome in Vietnam: A scoping review. JGH Open 5:11, pages 1227-1235.
Crossref
Crossref
Gregory S. Sayuk. (2021) Medical Therapies for Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterology Clinics of North America 50:3, pages 611-637.
Crossref
Crossref
Christopher J Black & Alexander Charles Ford. (2021) Best management of irritable bowel syndrome. Frontline Gastroenterology 12:4, pages 303-315.
Crossref
Crossref
Shin Fukudo, Toshikatsu Okumura, Masahiko Inamori, Yusuke Okuyama, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Akiko Shiotani, Yuji Naito, Yoshiko Fujikawa, Ryota Hokari, Tastuhiro Masaoka, Kazuma Fujimoto, Hiroshi Kaneko, Akira Torii, Kei Matsueda, Hiroto Miwa, Nobuyuki Enomoto, Tooru Shimosegawa & Kazuhiko Koike. (2021) Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. Journal of Gastroenterology 56:3, pages 193-217.
Crossref
Crossref
Esther Colomier, Joost Algera & Chloé Melchior. (2021) Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea. Frontiers in Pharmacology 11.
Crossref
Crossref
Aiya Aboubakr & Michelle S. Cohen. (2021) Functional Bowel Disease. Clinics in Geriatric Medicine 37:1, pages 119-129.
Crossref
Crossref
Xia Li, Bo Li, Jiaqi Zhang, Ting Chen, Haomeng Wu, Xiaoshuang Shi, Jinxin Ma, Jinyan Qin, Xudong Tang & Fengyun Wang. (2021) Efficacy of opioid receptor modulators in patients with irritable bowel syndrome. Medicine 100:4, pages e24361.
Crossref
Crossref
Imke Masuy, Jasper Pannemans & Jan Tack. (2020) Irritable bowel syndrome: diagnosis and management. Minerva Gastroenterologica e Dietologica 66:2.
Crossref
Crossref
Anna Zielińska. 2020. A Comprehensive Overview of Irritable Bowel Syndrome. A Comprehensive Overview of Irritable Bowel Syndrome
145
166
.
Rachel Vanderberg, Amy D. Lu & Jana G. Hashash. 2020. Sex- and Gender-Based Women's Health. Sex- and Gender-Based Women's Health
417
428
.
Martín Pérez-Pérez, Gael Pérez-Rodríguez, Florentino Fdez-Riverola & Anália Lourenço. (2019) Using Twitter to Understand the Human Bowel Disease Community: Exploratory Analysis of Key Topics. Journal of Medical Internet Research 21:8, pages e12610.
Crossref
Crossref
Alexander C. Ford. 2019. Evidence-based Gastroenterology and Hepatology 4e. Evidence-based Gastroenterology and Hepatology 4e
306
331
.
Anahita Sadeghi, Mohammad Biglari & Siavosh Nasseri Moghaddam. (2019) Post-infectious Irritable Bowel Syndrome: A Narrative Review. Middle East Journal of Digestive Diseases 11:2, pages 69-75.
Crossref
Crossref
Paul Moayyedi, Christopher N Andrews, Glenda MacQueen, Christina Korownyk, Megan Marsiglio, Lesley Graff, Brent Kvern, Adriana Lazarescu, Louis Liu, William G Paterson, Sacha Sidani & Stephen Vanner. (2019) Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). Journal of the Canadian Association of Gastroenterology 2:1, pages 6-29.
Crossref
Crossref
Jae Hak KimSam Ryong Jee. (2019) Irritable Bowel Syndrome. The Korean Journal of Gastroenterology 73:2, pages 84.
Crossref
Crossref
Sakteesh V. Gurunathan & Madhusudan Grover. 2019. Gastrointestinal Diseases and their Associated Infections. Gastrointestinal Diseases and their Associated Infections
85
95
.
Michael Camilleri. (2018) Management Options for Irritable Bowel Syndrome. Mayo Clinic Proceedings 93:12, pages 1858-1872.
Crossref
Crossref
J Pannemans & M Corsetti. (2018) Opioid receptors in the GI tract: targets for treatment of both diarrhea and constipation in functional bowel disorders?. Current Opinion in Pharmacology 43, pages 53-58.
Crossref
Crossref
Gisela Chelimsky & Thomas Chelimsky. (2018) The gastrointestinal symptoms present in patients with postural tachycardia syndrome: A review of the literature and overview of treatment. Autonomic Neuroscience 215, pages 70-77.
Crossref
Crossref
Qin Xiang Ng, Alex Yu Sen Soh, Donovan Yutong Lim & Wee‐Song Yeo. (2018) Agomelatine, a novel therapeutic option for the management of irritable bowel syndrome. Journal of Clinical Pharmacy and Therapeutics 43:5, pages 752-756.
Crossref
Crossref
Alexander C. Ford, Paul Moayyedi, William D. Chey, Lucinda A. Harris, Brian E. Lacy, Yuri A. Saito & Eamonn M. M. Quigley. (2018) American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. American Journal of Gastroenterology 113, pages 1-18.
Crossref
Crossref
Kyung Ho Song, Hye-Kyung Jung, Hyun Jin Kim, Hoon Sup Koo, Yong Hwan Kwon, Hyun Duk Shin, Hyun Chul Lim, Jeong Eun Shin, Sung Eun Kim, Dae Hyeon Cho, Jeong Hwan Kim & Hyun Jung Kim. (2018) Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. Journal of Neurogastroenterology and Motility 24:2, pages 197-215.
Crossref
Crossref
Victor Chedid, Priya Vijayvargiya & Michael Camilleri. (2018) Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline. Clinical Gastroenterology and Hepatology 16:3, pages 336-338.
Crossref
Crossref
Michael Camilleri & Alexander Ford. (2017) Pharmacotherapy for Irritable Bowel Syndrome. Journal of Clinical Medicine 6:11, pages 101.
Crossref
Crossref
Michael Camilleri, Anthony Lembo & David A. Katzka. (2017) Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits. Clinical Gastroenterology and Hepatology 15:9, pages 1338-1349.
Crossref
Crossref
Brian E Lacy, William D Chey, Brooks D Cash, Anthony J Lembo, Leonard S Dove & Paul S Covington. (2017) Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use. American Journal of Gastroenterology 112:6, pages 924-932.
Crossref
Crossref
Susan Lucak, Lin Chang, Albena Halpert & Lucinda A. Harris. (2016) Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice. Therapeutic Advances in Gastroenterology 10:2, pages 253-275.
Crossref
Crossref
Chan Hyuk Park & Dong Soo Han. (2017) Pharmacotherapy of irritable bowel syndrome. Journal of the Korean Medical Association 60:1, pages 57.
Crossref
Crossref
H. Duboc, M. Dior & B. Coffin. (2016) Le syndrome de l’intestin irritable : nouvelles pistes physiopathologiques et conséquences pratiques. La Revue de Médecine Interne 37:8, pages 536-543.
Crossref
Crossref
Brian E. Lacy, Fermín Mearin, Lin Chang, William D. Chey, Anthony J. Lembo, Magnus Simren & Robin Spiller. (2016) Bowel Disorders. Gastroenterology 150:6, pages 1393-1407.e5.
Crossref
Crossref
Robin Spiller. (2016) Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Research 5, pages 780.
Crossref
Crossref
Michael Camilleri & Alexander C. Ford. 2017. Gastrointestinal Pharmacology. Gastrointestinal Pharmacology
75
113
.
Judy Nee, Mohammed Zakari & Anthony J. Lembo. (2015) Novel Therapies in IBS-D Treatment. Current Treatment Options in Gastroenterology 13:4, pages 432-440.
Crossref
Crossref
Justin Sirianni, Mohab Ibrahim & Amol Patwardhan. 2015. Molecular and Cell Biology of Pain. Molecular and Cell Biology of Pain
565
611
.
Shin Fukudo, Hiroshi Kaneko, Hirotada Akiho, Masahiko Inamori, Yuka Endo, Toshikatsu Okumura, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Toshimi Chiba, Kenji Furuta, Shigeru Yamato, Tetsuo Arakawa, Yoshihide Fujiyama, Takeshi Azuma, Kazuma Fujimoto, Tetsuya Mine, Soichiro Miura, Yoshikazu Kinoshita, Kentaro Sugano & Tooru Shimosegawa. (2014) Evidence-based clinical practice guidelines for irritable bowel syndrome. Journal of Gastroenterology 50:1, pages 11-30.
Crossref
Crossref
Wakako Fujita, Ivone Gomes, Leonard S. Dove, David Prohaska, Gail McIntyre & Lakshmi A. Devi. (2014) Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers. Biochemical Pharmacology 92:3, pages 448-456.
Crossref
Crossref
Lin Chang, Anthony Lembo & Shahnaz Sultan. (2014) American Gastroenterological Association Institute Technical Review on the Pharmacological Management of Irritable Bowel Syndrome. Gastroenterology 147:5, pages 1149-1172.e2.
Crossref
Crossref
Jose L. Barboza, Nicholas J. Talley & Baharak Moshiree. (2014) Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome. Drugs 74:16, pages 1849-1870.
Crossref
Crossref
Alexander C Ford, Paul Moayyedi, Brian E Lacy, Anthony J Lembo, Yuri A Saito, Lawrence R Schiller, Edy E Soffer, Brennan M R Spiegel & Eamonn M M Quigley. (2014) American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation. American Journal of Gastroenterology 109, pages S2-S26.
Crossref
Crossref
Geoffrey C Wall, Ginelle A Bryant, Michelle M Bottenberg, Erik D Maki & Andrew R Miesner. (2014) Irritable bowel syndrome: A concise review of current treatment concepts. World Journal of Gastroenterology 20:27, pages 8796-8806.
Crossref
Crossref
Geoffrey C Wall, Ginelle A Bryant, Michelle M Bottenberg, Erik D Maki & Andrew R Miesner. (2014) Irritable bowel syndrome: A concise review of current treatment concepts. World Journal of Gastroenterology 20:27, pages 8796-8806.
Crossref
Crossref
Katy E. Trinkley & Milap C. Nahata. (2014) Medication Management of Irritable Bowel Syndrome. Digestion 89:4, pages 253-267.
Crossref
Crossref
Magnus Simrén & Hans TörnblomEleni Athanasakos & Anton Emmanuel. 2013. Irritable Bowel Syndrome: Diagnosis and Management. Irritable Bowel Syndrome: Diagnosis and Management
171
193
.
Magnus Simrén & Hans TörnblomMichael Camilleri. 2013. Irritable Bowel Syndrome: Diagnosis and Management. Irritable Bowel Syndrome: Diagnosis and Management
105
129
.
Hans Törnblom & Magnus Simrén. 2013. Irritable Bowel Syndrome. Irritable Bowel Syndrome
277
299
.
Arnold Wald. (2012) Irritable bowel syndrome – Diarrhoea. Best Practice & Research Clinical Gastroenterology 26:5, pages 573-580.
Crossref
Crossref
William D. Chey, Monthira Maneerattaporn & Richard Saad. (2011) Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome. Gut and Liver 5:3, pages 253-266.
Crossref
Crossref
K. E. Trinkley & M. C. Nahata. (2011) Treatment of irritable bowel syndrome. Journal of Clinical Pharmacy and Therapeutics 36:3, pages 275-282.
Crossref
Crossref
Richard J. Saad. (2011) Peripherally Acting Therapies for the Treatment of Irritable Bowel Syndrome. Gastroenterology Clinics of North America 40:1, pages 163-182.
Crossref
Crossref
Joong Goo KwonKyung Sik ParkJung Ho ParkJae Myung ParkCheol Hee ParkKwang Jae LeeHyo-Jin ParkJong Chul Rhee. (2011) Guidelines for the Treatment of Irritable Bowel Syndrome. The Korean Journal of Gastroenterology 57:2, pages 82.
Crossref
Crossref
Sarah Khan & Lin Chang. (2010) Diagnosis and management of IBS. Nature Reviews Gastroenterology & Hepatology 7:10, pages 565-581.
Crossref
Crossref
Alexander C Ford, Paul Moayyedi & Nicholas J Talley. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
355
376
.
Kok-Ann Gwee, Young-Tae Bak, Uday Chand Ghoshal, Sutep Gonlachanvit, Oh Young Lee, Kwong Ming Fock, Andrew Seng Boon Chua, Ching-Liang Lu, Khean-Lee Goh, Chomsri Kositchaiwat, Govind Makharia, Hyo-Jin Park, Full-Young Chang, Shin Fukudo, Myung-Gyu Choi, Shobna Bhatia, Meiyun Ke, Xiaohua Hou & Michio Hongo. (2010) Asian consensus on irritable bowel syndrome. Journal of Gastroenterology and Hepatology 25:7, pages 1189-1205.
Crossref
Crossref
Brian E. Lacy, Kirsten Weiser & Ryan De Lee. (2009) Review: The treatment of irritable bowel syndrome. Therapeutic Advances in Gastroenterology 2:4, pages 221-238.
Crossref
Crossref
Lawrence J. Brandt, William D. Chey, Amy E. Foxx-Orenstein, Eamonn M.M. Quigley, Lawrence R. Schiller, Philip S. Schoenfeld, Brennan M. Spiegel, Nicholas J. Talley & Paul Moayyedi. (2009) An Evidence-Based Systematic Review on the Management of Irritable Bowel Syndrome. American Journal of Gastroenterology 104, pages S8-S35.
Crossref
Crossref
M. Mnguez Prez, B. Herreros Martnez, F. Mora Miguel & A. Benages Martnez. (2008) S?ndrome del intestino irritable. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 10:6, pages 349-355.
Crossref
Crossref
Tom Kraft & David Kraft. (2007) Irritable bowel syndrome: symptomatic treatment versus integrative psychotherapy. Contemporary Hypnosis 24:4, pages 161-177.
Crossref
Crossref
C. L. FRISSORA & B. D. CASH. (2007) Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 25:11, pages 1271-1281.
Crossref
Crossref
Mihaela Podovei & Braden Kuo. (2006) Irritable Bowel Syndrome: A Practical Review. Southern Medical Journal 99:11, pages 1235-1242.
Crossref
Crossref
H. Mönnikes, M. Schmidtmann & I. R. van der Voort. (2006) Arzneimitteltherapie des ReizdarmsyndromsDrug therapy for irritable bowel syndrome. Der Internist 47:10, pages 1073-1083.
Crossref
Crossref
J. TACK, M. FRIED, L. A. HOUGHTON, J. SPICAK & G. FISHER. (2006) Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective. Alimentary Pharmacology and Therapeutics 24:2, pages 183-205.
Crossref
Crossref
R. HEADING, K. BARDHAN, S. HOLLERBACH, A. LANAS & G. FISHER. (2006) Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome - a European perspective. Alimentary Pharmacology and Therapeutics 24:2, pages 207-236.
Crossref
Crossref
Howard Y. Chang, Eoin C. Kelly & Anthony J. Lembo. (2006) Current gut-directed therapies for irritable bowel syndrome. Current Treatment Options in Gastroenterology 9:4, pages 314-323.
Crossref
Crossref
Philip Schoenfeld. (2005) Efficacy of Current Drug Therapies in Irritable Bowel Syndrome: What Works and Does Not Work. Gastroenterology Clinics of North America 34:2, pages 319-335.
Crossref
Crossref
D. Lesbros-Pantoflickova, P. Michetti, M. Fried, C. Beglinger & A. L. Blum. (2004) Meta-analysis: the treatment of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 20:11-12, pages 1253-1269.
Crossref
Crossref
R.C. Spiller. (2004) Inflammation as a basis for functional GI disorders. Best Practice & Research Clinical Gastroenterology 18:4, pages 641-661.
Crossref
Crossref
M. Mnguez Prez, B. Herreros Martnez, F. Mora Miguel & A. Benages Martnez. (2004) S?ndrome del intestino irritable. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:4, pages 246-252.
Crossref
Crossref
Nicholas J. Talley. (2003) Evaluation of drug treatment in irritable bowel syndrome. British Journal of Clinical Pharmacology 56:4, pages 362-369.
Crossref
Crossref
Robin C. Spiller. (2003) Treatment of irritable bowel syndrome. Current Treatment Options in Gastroenterology 6:4, pages 329-337.
Crossref
Crossref
Driss Berrada, Katia Canenguez & Tony Lembo. (2003) New approaches to the medical treatment of irritable bowel syndrome. Current Gastroenterology Reports 5:4, pages 337-342.
Crossref
Crossref
Robin C. Spiller. (2003) Postinfectious irritable bowel syndrome1 1Abbreviations used in this paper: EC,_; IBS, irritable bowel syndrome; PI, postinfective.. Gastroenterology 124:6, pages 1662-1671.
Crossref
Crossref
Laurent Diop, Frederic Raymond, Helene Fargeau, Francine Petoux, Maria Chovet & Annette M. Doherty. (2002) Pregabalin (CI-1008) Inhibits the Trinitrobenzene Sulfonic Acid-Induced Chronic Colonic Allodynia in the Rat. Journal of Pharmacology and Experimental Therapeutics 302:3, pages 1013-1022.
Crossref
Crossref
Michael J. Callahan. (2002) Irritable Bowel Syndrome Neuropharmacology. Journal of Clinical Gastroenterology 35:Supplement, pages S58-S67.
Crossref
Crossref
Michael Camilleri. (2001) Management of the irritable bowel syndrome. Gastroenterology 120:3, pages 652-668.
Crossref
Crossref
Rebecca C. Dunphy & G. Nicholas Verne. (2001) Drug Treatment Options for Irritable Bowel Syndrome. Drugs & Aging 18:3, pages 201-211.
Crossref
Crossref
G. Ragnarsson & G. Bodemar. (2000) Treatment of irritable bowel syndrome with loperamide oxide. An open study to determine optimal dosage. Journal of Internal Medicine 248:2, pages 165-166.
Crossref
Crossref
Jeffrey L Jackson, Patrick G O’Malley, Glen Tomkins, Erin Balden, James Santoro & Kurt Kroenke. (2000) Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis11The opinions in this article represent those of the authors and are not to be construed, in any way, to represent those of the U.S. Army or the Department of Defense.. The American Journal of Medicine 108:1, pages 65-72.
Crossref
Crossref
R. Wanitschke. 2000. Phytopharmaka VI. Phytopharmaka VI
183
191
.
Robin C Spiller. (1999) Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. The American Journal of Medicine 107:5, pages 91-97.
Crossref
Crossref
Elizabeth O'Keefe & Nicholas J. Talley. (1991) The Irritable Bowel Syndrome in the Elderly. Gastroenterology Clinics of North America 20:2, pages 369-390.
Crossref
Crossref
Gerald Friedman. (1991) Treatment of the Irritable Bowel Syndrome. Gastroenterology Clinics of North America 20:2, pages 325-333.
Crossref
Crossref
Elizabeth O’Keefe & Nicholas J. Talley. (1991) Irritable Bowel Syndrome in the Elderly. Clinics in Geriatric Medicine 7:2, pages 265-286.
Crossref
Crossref
William J. Kinnier, James F. Kachur, Vicki H. Audia & Carl Kaiser. (2006) Irritable bowel syndrome: Present and prospective pharmacological intervention. Medicinal Research Reviews 9:3, pages 325-342.
Crossref
Crossref
Kenneth B. Klein. (1988) Controlled treatment trials in the irritable bowel syndrome: A critique. Gastroenterology 95:1, pages 232-241.
Crossref
Crossref